Immunomodulatory Effect of H. Pylori CagA Genotype and Gastric Hormones On Gastric Versus Inflammatory Cells Fas Gene Expression in Iraqi Patients with Gastroduodenal Disorders by Al-Ezzy, Ali Ibrahim Ali
 _______________________________________________________________________________________________________________________________ 
  364                                                                                                                                                                                                                     http://www.mjms.mk/ 
http://www.id-press.eu/mjms/ 
 
ID Design 2012/DOOEL Skopje, Republic of Macedonia 
Open Access Macedonian Journal of Medical Sciences. 2016 Sep 15; 4(3):364-373. 
http://dx.doi.org/10.3889/oamjms.2016.032 
eISSN: 1857-9655 
Basic Science 
  
 
 
 
Immunomodulatory Effect of H. Pylori CagA Genotype and 
Gastric Hormones On Gastric Versus Inflammatory Cells Fas 
Gene Expression in Iraqi Patients with Gastroduodenal 
Disorders 
 
 
Ali Ibrahim Ali AL-Ezzy
*
 
 
Department of Pathology, College of Veterinary Medicine, Diyala University, Baquba, Diyala Province, Iraq 
 
 
Citation: AL-Ezzy AIA. Immunomodulatory Effect of H. 
Pylori CagA Genotype and Gastric Hormones On Gastric 
Versus Inflammatory Cells Fas Gene Expression in Iraqi 
Patients with Gastroduodenal Disorders. Open Access 
Maced J Med Sci. 2016 Sep 15; 4(3):364-373. 
http://dx.doi.org/10.3889/oamjms.2016.032 
Key words: Fas gene; gastric disorders; pepsinogens; 
gastrin -17; H. pylori, CagA. 
*Correspondence: Ali Ibrahim Ali Al-Ezzy. Department of 
Pathology, College of Veterinary Medicine, Diyala 
University, Baquba, Diyala Province, Iraq. E-mail: 
alizziibrahim@gmail.com 
Received: 23-Jan-2016; Revised: 19-Feb-2016; 
Accepted: 20-Feb-2016; Online first: 15-Mar-2016 
Copyright: © 2016 Ali Ibrahim Ali AL-Ezzy. This is an 
open access article distributed under the terms of the 
Creative Commons Attribution License, which permits 
unrestricted use, distribution, and reproduction in any 
medium, provided the original author and source are 
credited. 
Competing Interests: The authors have declared that no 
competing interests exist. 
 
 
 
 
 
 
 
 
 
 
 
Abstract  
AIM: To evaluate the Immunomodulatory effects of CagA expression; pepsinogen I, II & gastrin-17 
on PMNs and lymphocytes Fas expression in inflammatory and gastric cells; demographic 
distribution of Fas molecule in gastric tissue and inflammatory cells.  
METHODS: Gastroduodenal biopsies were taken from 80 patients for histopathology and H. pylori 
diagnosis. Serum samples were used for evaluation of pepsinogen I (PGI); (PGII); gastrin-17 (G-
17). 
RESULTS: Significant difference (p < 0.001) in lymphocytes & PMNs Fas expression; epithelial & 
lamina propria Fas localization among H. pylori associated gastric disorders. No correlation 
between grade of lymphocytes & PMNs Fas expression in gastric epithelia; lamina propria and 
types of gastric disorder. Significant difference (p < 0.001) in total gastric Fas expression, epithelial 
Fas; lamina propria and gastric gland Fas expression according to CagA, PGI; PGII; PGI/PGII; 
Gastrin-17. Total gastric Fas expression has significant correlation with CagA, PGII levels. Gastric 
epithelial and gastric lamina propria Fas expression have significant correlation with CagA, PGI; 
PGII levels. Significant difference (p < 0.001) was found in lymphocytes & PMNs Fas expression; 
epithelial & lamina propria localization of lymphocytes & PMNs Fas expression according to CagA, 
PGI; PGII; PGI/PGII; Gastrin-17. Lymphocytes Fas expression have correlation with PGI, PGII, 
PGI/PGII. PMNs Fas expression have correlation with PGI, PGII. 
CONCLUSION: Fas gene expression and localization on gastric and inflammatory cells affected 
directly by H. pylori CagA and indirectly by gastric hormones. This contributes to progression of 
various gastric disorders according to severity of CagA induced gastric pathology and gastric 
hormones disturbance throughout the course of infection and disease. 
 
 
 
Introduction 
 
Helicobacter pylori infection is associated with 
several benign and malignant human diseases. Most 
infected individuals remain asymptomatic. If 
untreated, infection lasts for decades .The prevalence 
of infection ranging between 50% in developed 
countries and 90% in developing countries [1].  
H. pylori occupies a unique niche, extremely 
acidic environment [2]. The urease of H. pylori is 
essential for its colonization and survival at extremely 
low pH, to ensure cytoplasmic homeostasis during 
large pH changes that occur during feeding. H. pylori 
can use molecular hydrogen as energy source; thus, 
its growth depends to some extent on the hydrogen 
excreted [3]. H. pylori infected gastric mucosa evolves 
through stages of chronic gastritis, intestinal 
metaplasia, glandular atrophy, and dysplasia before 
carcinoma develops. 
H. pylori Infection is associated mostly with 
chronic antral gastritis, characterized by a mucosal 
inﬁltration of polymorphonuclear (PMNs) and 
mononuclear leukocytes [4]. Some studies have 
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reported that H. pylori infection is suggested by the 
presence of active inflammation [3]. Neutrophil 
infiltration is a hallmark of active inflammation [4]. It is 
unknown whether neutrophil infiltration may be a 
marker of H. pylori infection. 
It is now established that Helicobacter pylori 
causes more than 80% of duodenal ulcers and up to 
60% of gastric ulcers [3]. The link between 
Helicobacter pylori infection and subsequent gastritis 
and peptic ulcer disease has been established 
through studies of human volunteers, antibiotic 
treatment studies and epidemiological studies. In 
some individuals, Helicobacter pylori also infect the 
corpus region of the stomach. This results in a more 
widespread inflammation that predisposes not only to 
ulcer in the corpus region, but also to stomach cancer 
[3]. 
Because of extremely low pH, the stomach is 
a hostile environment to most other microorganisms. 
The ability of H. pylori to flourish in the stomach has 
been attributed to protective mechanisms such as its 
production of urease, protecting the bacterium from 
gastric acidity by creating a basic microenvironment 
[5]. However, we reasoned that H. pylori might have 
evolved away to gain growth advantage in this niche, 
possibly by exploiting a gastric factor. A logical 
candidate would be one up regulated by H. pylori 
infection. 
One such factor is the gastric hormone 
gastrin. Gastrin is produced as a prohormone by G 
cells located within the gastric antrum. The 
prohormone processed to shorter peptides, the most 
abundant of which is 17 amino acids long, termed 
gastrin-17 (G17). The major role attributed to gastrin 
within gastric tissue is the regulation of acid secretion 
[6]. After infection, gastrin levels are found to be 
consistently elevated and normal physiological 
negative feedback control of secretion is lost. 
Furthermore, after H. pylori eradication, gastrin levels 
are reduced and normal feedback control of gastrin 
secretion is restored [6, 7]. 
A number of studies have investigated the 
pathogenicity of H. pylori in relation to cytotoxic 
products, including urease, Cag, and vacuolating toxin 
(VacA) [8]. Potential apoptosis-inducing activity was 
reported in VacA [8] and urease [9]. Apoptosis in H. 
pylori-associated gastritis accompanies the activation 
of Fas and the Fas ligand system [10] in epithelial 
cells. Fas is a member of the tumor necrosis factor 
receptor family, which, when bound by its ligand, 
activates caspase-8, an initiator of the downstream 
apoptotic process that includes the cleavage of other 
death substrates, cellular and nuclear morphological 
changes and, ultimately, cell death [11]. Variations in 
host responses might cause the H. pylori mediated 
pathogenesis to result in a variety of clinical 
outcomes.  
The aim of the present study is to evaluate 
the Immunomodulatory effects of CagA gene 
expression and gastric secretions (pepsinogen I, -II, 
Gastrin17) on inflammatory response mainly PMNs 
and lymphocytes infiltrations as well as expression of 
Fas gene in inflammatory and gastric cells under 
influence of CagA and gastric hormones and 
demographic distribution of Fas molecule in gastric 
tissue and inflammatory cells.  
 
 
Materials and Methods 
 
Patients 
In this cross sectional study, (80) patients, 
age range 16-80 years, mean (47.24 ± 18.82) years, 
with clinical indications for upper gastrointestinal tract 
endoscopy during June 2013 to January 2015 were 
studied. Males represent 44 (55%) versus 36 (45%) 
females. This study was conducted according to the 
principles of Helsinki declaration. Before endoscopy, a 
full explanation about the purpose of this study to all 
patients was done. Dully-filled consent form obtained 
from all patients that agree to participate in the study. 
Approval of ethical review Committee of College of 
medicine – Diyala University - Iraq, was taken prior to 
initiation of the work at gastroenterology department 
of Baqubah teaching hospital in Diyala province - Iraq. 
Any patient under antibiotics or colloidal bismuth 
compounds for past one month treatment; having a 
history of previous gastric surgery and recent or active 
gastrointestinal bleeding was excluded from this 
study. 
 
Methods 
After topical pharyngeal anesthesia for 
overnight fasted Patients, A sterile flexible endoscope 
was introduced for full investigation of Stomach and 
duodenum. Six biopsy samples from congested, 
inflamed or erosive lesions were picked via sterile 
biopsy forceps. Samples were placed in Serim® 
PyloriTek® Test Kit for detection of urease activity. 
Each PyloriTek strip has a built-in positive analyte 
control and a negative control, which run concurrently 
with the test specimen. The PyloriTek positive control 
automatically appears with every test within the 
normal 1-hour time. With competitive tests the positive 
control is run after waiting 24 hours then inserting a 
urease positive control material [12]. 
Biopsy sample was placed in sterile glass 
slide with a drop of normal saline and teased with 
sterile scalpel to make smaller fragments of tissue 
then another sterile glass slide was placed over the 
teased first tissue and the tissue was crushed 
between the two glasses then stain by Gram’s 
staining. Existence of Gram negative spiral bacteria 
embedded in the tissue cells was diagnostic for H. 
pylori [13]. 
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True positive results were considered if a 
combination of urease test and Gram stain give 
positive results for a single biopsy specimen [14]. 
Human Fas gene and H. pylori CagA gene 
expression detected by insitu hybridization procedure 
in 5µm thickness serial gastric mucosal sections fixed 
on positively charged slides using biotinylated long 
DNA probe for Human Fas gene; Cat. No. IH-60047 
(fas-6001-B); H. pylori/ CagA gene, Cat. No. IH-60061 
(HPY-6001-B) (Maxim biotech-USA) and the DNA 
Probe hybridization/Detection System – In Situ Kit 
(Maxim biotech-USA), according to Maxim biotech 
instruction manual [15].The examination and scoring 
were done under light microscope by pathologists at 
power X 400 according to the scoring system [16]. For 
serological assay blood was drawn from each patient 
during the visit to the endoscopy unit. Separated 
serum samples were stored at 27˚C until analyses. 
Serum pepsinogen I(PGI) and II(PGII) and gastrin-17 
(G-17) were assayed with ELISA using monoclonal 
antibodies to pepsinogen I and II and gastrin-17 
(Biohit Diagnostics, Biohit, Devon, UK). All procedures 
were carried out according to the manufacturer’s 
instructions and results of pepsinogen I and II 
reported in µg/l and pmol/l for gastrin-17. The 
pepsinogen I: II ratio was calculated and reported in 
fraction [17].  
 
Statistical analysis 
Frequency of variables express as 
percentage. PG I, II and G-17 values express as 
mean ± standard deviation (Mean ± SD). Pearson test 
for correlation was used for non-categorical data. Chi-
test used to compare the PG I, PGII, and G17 
according to CagA gene expression.  
The level of significance was 0.05 (two-tail) in 
all statistical testing; significant of correlations 
(Pearson, spearman) include also 0.01 (two-tail). 
Statistical analysis was performed using SPSS for 
windows TM version 17.0, and Microsoft Excel for 
windows 2010. 
 
 
Results 
 
As shown in Table 1 gastric infiltrated 
lymphocytes have mild Fas expression in (61.25%) 
versus (31.25%) moderate expression (Figure1). Mild 
and moderate lymphocytes Fas expression reported 
mainly in gastritis (25%) and lastly in, duodenitis 
(3.75%) and prepyloric ulcer (2.5%). Significant 
difference reported (p < 0.001) in lymphocytes Fas 
expression without correlation between grade of Fas 
expression and types of gastric disorder (p = 0.266). 
Gastric infiltrated PMNs have mild Fas gene 
expression in (46.25%), mainly in gastritis (12.5%) 
and lastly in prepyloric ulcer (2.5%) (Figure1). 
Moderate PMNS Fas expression reported in (3.75%) 
in gastric ulcer and gastritis. Significant difference 
reported (p < 0.001) in PMNs Fas expression without 
correlation between grade of Fas expression and 
types of gastric disorder (p = 0.643).  
 
Table 1: Lymphocytes and PMNs Fas gene expression and localization in gastroduodenal disorders  
Presentation 
Lymphocyte Fas gene 

2
 P value R P value 
˂5% 5-25% 26-50% 50% ˃ Total 
Gastric ulcer 1 (1.25%) 10 (12.5%) 4 (5%) 0 (0%) 15 (18.75%) 
197.467 0.000 0.126 0.266 
Du 0 (0%) 6 (7.5%) 6 (7.5%) 0 (0%) 12 (15%) 
Gastropathy 3 (3.75%) 10 (12.5%) 2 (2.5%) 0 (0%) 15 (18.75%) 
Gastritis 2 (2.5%) 20 (25%) 8 (10%) 0 (0%) 30 (37.5%) 
Duodenitis 0 (0%) 3 (3.75%) 3 (3.75%) 0 (0%) 6 (7.5%) 
Prepyloric ulcer 0 (0%) 0 (0%) 2 (2.5%) 0 (0%) 2 (2.5%) 
Total 6 (7.5%) 49 (61.25%) 25 (31.25%) 0 (0%) 80 (100%) 
Presentation PMNs Fas gene 
Gastric ulcer 6 (7.5%) 7 (8.75%) 2 (2.5%) 0 (0%) 15 (18.75%) 
147.179 0.000 -0.053 0.643 
Du 5 (6.25%) 7 (8.75%) 0 (0%) 0 (0%) 12 (15%) 
Gastropathy 9 (11.25%) 6 (7.5%) 0 (0%) 0 (0%) 15 (18.75%) 
Gastritis 19 (23.75%) 10 (12.5%) 1 (1.25%) 0 (0%) 30 (37.5%) 
Duodenitis 1 (1.25%) 5 (6.25%) 0 (0%) 0 (0%) 6 (7.5%) 
Prepyloric ulcer 0 (0%) 2 (2.5%) 0 (0%) 0 (0%) 2 (2.5%) 
Total 40 (50%) 37 (46.25%) 3 (3.75%) 0 (0%) 80 (100%) 
Presentation 
Cellular Fas gene expressed in epithelial lining 

2
 P value R P value 
˂5% 5-25% 26-50% 50% ˃ Total 
Gastric ulcer 0 (0%) 11 (13.75%) 4 (5%) 0 (0%) 15 (18.75%) 
162.347 0.000 0.036 0.754 
Du 0 (0%) 4 (5%) 8 (10%) 0 (0%) 12 (15%) 
Gastropathy 0 (0%) 9 (11.25%) 6 (7.5%) 0 (0%) 15 (18.75%) 
Gastritis 0 (0%) 14 (17.5%) 16 (20%) 0 (0%) 30 (37.5%) 
Duodenitis 0 (0%) 6 (7.5%) 0 (0%) 0 (0%) 6 (7.5%) 
Prepyloric ulcer 0 (0%) 0 (0%) 2 (2.5%) 0 (0%) 2 (2.5%) 
Total 0 (0%) 44 (55%) 36 (45%) 0 (0%) 80 (100%) 
Presentation Cellular Fas gene expressed in lamina propria 
Gastric ulcer 0 (0%) 0 (0%) 0 (0%) 15 (18.75%) 15 (18.75%) 
162.347 0.000 -0.036 0.754 
Du 0 (0%) 0 (0%) 0 (0%) 12 (15%) 12 (15%) 
Gastropathy 0 (0%) 0 (0%) 0 (0%) 15 (18.75%) 15 (18.75%) 
Gastritis 0 (0%) 0 (0%) 0 (0%) 30 (37.5%) 30 (37.5%) 
Duodenitis 0 (0%) 0 (0%) 0 (0%) 6 (7.5%) 6 (7.5%) 
Prepyloric ulcer 0 (0%) 0 (0%) 0 (0%) 2 (2.5%) 2 (2.5%) 
Total 0 (0%) 0 (0%) 0 (0%) 80 (100%) 80 (100%) 
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Figure 1:  In situ hybridization for human Fas in gastric tissue 
section mainly in inflammatory cell infiltrates (A)  lymphocytes; (B) 
PMNS, (C) negative expression. Bar size = 50 µm. staining by 
BCIP/NBT (bluish purple) counterstained with nuclear fast red 
 
Mild (55%) to moderate (45%) Fas gene 
expression on inflammatory cells (lymphocytes and 
PMNs) infiltrated in gastric epithelial lining were 
reported. Mild Fas expression detected mainly in in 
gastritis (17.5%) and lastly in DU (5%). Moderate Fas 
expression detected in gastritis (20%), and finally in 
prepyloric ulcer (2.5%). There was significant 
difference (p < 0.001) in epithelial localization of 
lymphocytes & PMNs Fas among disorders without 
correlation (p = 0.754). Fas overexpression was 
detected in lymphocytes and PMNs infiltrated in 
lamina propria, mainly in gastritis (37.5%), gastric 
ulcer & gastropathy (18.75%), prepyloric ulcer (2.5%). 
There was significant difference (p < 0.001) in lamina 
propria localization of Fas expressing lymphocytes & 
PMNs among disorders without correlation (p = 
0.754). 
As shown in Table 2, overexpression of Fas 
on gastric cells reported in (61.25%), moderate 
expression (31.25%), mild expression (5%). A sum of 
(58.75%) of gastroduodenal disorders infected with 
CagA positive H. pylori (Figure 2), (43.75%) have 
gastric Fas overexpression. Significant difference in 
Fas expression among disorders correlated with 
between CagA expression (p value < 0.001, p value = 
0.001). 
Fas over expression reported in (7.5%) 
gastric disorders with hypopepsinogenemia, (31.25%) 
cases with normal PGI; (22.5%) with PGI 
hypersecretion. Moderate Fas expression reported in 
(27.5%) cases with normal PGI and (3.75%) with PGI 
hypersecretion. Significant difference among 
disorders in grade of Fas expression (p value < 0.001) 
without correlation with serum level of PGI (p value = 
0.643). 
 
 
 
Figure 2: In situ hybridization for CagA Positive H. pylori in gastric 
tissue section .staining by BCIP/NBT (bluish purple) counterstained 
with nuclear fast red. Bar size=50 µm. A) Gastric epithelia, B) CagA 
expression extended to gastric pits, C) negative expression 
 
Fas over expression reported in (15%) gastric 
disorders with normal PGII level; (46.25%) of cases 
with hypersecretion of PGII. Significant difference 
among disorders in grade of Fas expression (p value 
< 0.001) with correlation with serum level of PGII (p 
value = 0.01).  
Gastric Fas over expression reported in 
(27.5%) of cases with PGI/PGII hyposecretion; 
(33.75%) of normal PGI/PGII. Significant difference 
among disorders in grade of Fas expression (p value 
1-A 
1-B 
1-C 
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< 0.001) without correlation with serum level of 
PGI/PGII (p value = 0.156). Significant difference in 
grade of Fas gene expression (p value < 0.001) 
without correlation with gastrin17 level (p value = 
0.858). 
  
  
Figure 3: In situ hybridization for Fas gene in gastric tissue section. 
Staining by BCIP/NBT (bluish purple) counterstained with nuclear 
fast red. Bar size = 50 µm. A)  positive  Fas gene In situ 
hybridization expression in gastric epithelia; (B)  positive  Fas gene 
In situ hybridization expression in gastric lamina propria; (C) 
positive  Fas gene In situ hybridization expression in gastric glands; 
(D) Negative In situ hybridization for Fas gene in gastric tissue 
section. 
 
As in Table 3, gastric epithelia have mild Fas 
expression (61.25%) versus (38.75%) for moderate. 
H. pylori CagA infected gastric epithelia has moderate 
Fas expression in (26.25%) versus (32.5%) in mild 
with significant difference and correlation between 
CagA expression and grade of Fas expression (p 
value < 0.001, p value = 0.05) (Figure3). Significant 
difference in grade of Fas gene expression (p value < 
0.001) with correlation between serum level of PGI 
and Fas grade (p value < 0.001).  
Significant difference in gastric epithelia Fas 
grade (p value < 0.001) with correlation between PGII 
levels (p value = 0.0002). Among (58.75%) patients of 
normal PGI/PGII, (25%) have moderate grade of 
gastric Fas expression, (33.75%) mild. Significant 
difference in grade of gastric epithelial Fas expression 
(p value < 0.001) without correlation between level of 
PGI/PGII and grade Fas expression (p value = 0.487). 
Normal Gastrin17 detected in (87.5%), (37.5%) have 
moderate Fas expression and (50%) was mild. 
Hypergastrinemia was detected in (12.5%), (1.25%) 
have moderate Fas expression, (11.25%) mild. 
Significant difference in grade of Fas expression (p 
value < 0.001) without correlation between gastrin17 
and grade of Fas expression (p value = 0.508). 
As shown in Table 4, mild Fas expression in 
lamina propria (56.25%) versus (43.75%) moderate. 
Significant difference and correlation between CagA 
expression and Fas expression in lamina propria (p 
value = 0.001, p value = 0.056) (Figure3). Significant 
difference among disorders in grade of Fas 
expression (p value < 0.001) with significant 
correlation between serum PGI and grade of Fas 
expression in gastric lamina propria (p value = 0.05). 
Normal PGII level detected in (23.75%) patients, 
(15%) have moderate grade of Fas expression and 
(8.75%) was mild. Hypersecretion of PGII was 
determined in (76.25%) patients, (28.75%) have 
moderate grade of gastric Fas expression, (47.5%) 
was mild. Significant difference in grade of Fas 
expression (p value < 0.001) with correlation between 
PGII level and grade of Fas expression in gastric 
lamina propria (p value = 0.001). Significant difference 
in grade of Fas expression in gastric lamina propria (p 
value < 0.001) without correlation between serum 
PGI/PGII and grade of gastric lamina propria Fas 
expression (p value = 0.519). Significant difference in 
grade of Fas expression (p value < 0.001) without 
correlation between gastrin17 level and grade of 
gastric lamina propria Fas expression (p value = 
0.575). 
 
Table 2: Correlation of Gastric cells Fas gene expression and gastric secretion 
Parameters 
Gastric  cells  Fas gene 
2
 
 
P value R P value 
˂5% 5-25% 26-50% 50% ˃ Total 
CagA 
genotype 
Positive 0(0%) 4 (5%) 8 (10%) 35 (43.75%) 47 (58.75%) 60.363 
 
0.000 
0.350 
 
0.001 
Negative 2 (2.5%) 0 (0%) 17 (21.25%) 14 (17.5%) 33 (41.25%) 
PGI 
˂30  µg/L 0 (0%) 0 (0%) 0 (0%) 6 (7.5%) 6 (7.5%) 
1149.995 0.000 -0.053 0.643 30-160 µg/L 2 (2.5%) 0 (0%) 22 (27.5%) 25 (31.25%) 49 (61.25%) 
˃160 µg/L 0 (0%) 4 (5%) 3 (3.75%) 18 (22.5%) 25 (31.25%) 
PGII 
˂3  µg/L 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 
1088.09 
 
0.000 
0.285 
 
0.01 3-15 µg/L 0 (0%) 0 (0%) 7 (8.75%) 12 (15%) 19 (23.75%) 
˃15 µg/L 2 (2.5%) 4 (5%) 18 (22.5%) 37 (46.25%) 61 (76.25%) 
PGI/PGII 
˂3  µg/L 2 (2.5%) 0 (0%) 9 (11.25%) 22 (27.5%) 33 (41.25%) 
1833.79 
 
0.000 
-0.163 
 
0.156 3-20 µg/L 0 (0%) 4 (5%) 16 (20%) 27 (33.75%) 47 (58.75%) 
˃20 µg/L 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 
Gastrin-17 
˂ 1 pmol/ml 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 
586.08 0.000 0.020 0.858 
1-7 pmol/ml 2 (2.5%) 4 (5%) 19 (23.75%) 45 (56.25%) 70 (87.5%) 
˃7  pmol/ml 0 (0%) 0 (0%) 6 (7.5%) 4 (5%) 10 (12.5%) 
Total 2 (2.5%) 4 (5%) 25 (31.25%) 49 (61.25%) 80 (100%) 
3-A  3- B  
3-C  3-D  
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Table 3: Correlation of Gastric epithelial cells  Fas gene expression and gastric secretion 
Parameters 
Gastric cells epithelial Fas gene 
2
 
 
P value R P value 
˂5% 5-25% 26-50% 50% ˃ Total 
CagA  
Genotype  
Positive  0 (0%) 26 (32.5%) 21 (26.25%) 0 (0%) 47 (58.75%) 
40.177 0.000 
0.213 
0.218* 
0.058 
0.052* Negative  0 (0%) 23 (28.75%) 10 (12.5%) 0 (0%) 33 (41.25%) 
PGI 
˂30  µg/l 0 (0%) 6 (7.5%) 0 (0%) 0 (0%) 6 (7.5%) 
671.43 0.000 0.405 0.000 30-160 µg/L 0 (0%) 34 (42.5%) 15 (18.75%) 0 (0%) 49 (61.25%) 
˃160 µg/L 0 (0%) 9 (11.25%) 16 (20%) 0 (0%) 25 (31.25%) 
PGII 
˂3  µg/l 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 
650.29 0.000 0.341 0.002 3-15 µg/L 0 (0%) 15 (18.75%) 4 (5%) 0 (0%) 19 (23.75%) 
˃15 µg/L 0 (0%) 34 (42.5%) 27 (33.75%) 0 (0%) 61 (76.25%) 
PGI/PGII  
˂3  µg/l 0 (0%) 22 (27.5%) 11 (13.75%) 0 (0%) 33 (41.25%) 
1044.64 0.000 0.079 0.487 3-20 µg/L 0 (0%) 27 (33.75%) 20 (25%) 0 (0%) 47 (58.75%) 
˃20 µg/L 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 
Gastrin-17 
˂ 1 pmol/ml 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 
348.498 0.000 -0.075 0.508 1-7 pmol/ml 0 (0%) 40 (50%) 30 (37.5%) 0 (0%) 70 (87.5%) 
˃7 pmol/ml 0 (0%) 9 (11.25%) 1 (1.25%) 0 (0%) 10 (12.5%) 
 
* Spearman Correlation 
 
 
As shown in Table 4, Fas overexpression 
appear to be more frequent (53.75%) than moderate 
(41.25%) and mild (5%) grade of expression in gastric 
glands. Significant difference without correlation 
between CagA expression and grade of Fas in gastric 
glands (p value = 0.001, p value = 0.743). 
Significant difference in grade of Fas 
expression (p value < 0.001) without significant 
correlation between serum PGI and grade of gastric 
glands Fas expression (p value = 0.296).Significant 
difference among disorders in grade of Fas (p value < 
0.001) without correlation between serum PGII and 
grade of gastric glands Fas expression (p value = 
0.501). Significant difference in grade of gastric gland 
Fas expression (p value < 0.001) without correlation 
between PGI/PGII serum level and grade of gastric 
cells Fas (p value = 0.947). Significant difference 
among disorders in grade of Fas gene expression (p 
value < 0.001) without correlation between gastrin17 
and grade of gastric glands Fas expression (p value = 
0.286). 
As shown in Table 5, moderate lymphocytes 
Fas expression detected in (31.25%) versus (27.5%) 
mild among CagA positive cases. Significant 
difference without correlation between CagA 
expression and grade of Fas in lymphocytes (p value 
= 0.001, p value = 0.112). Significant difference in 
grade of Fas (p value < 0.001) with significant 
correlation between serum PGI and grade of 
lymphocytes Fas expression (p value = 0.009).Normal 
PGII level detected in (23.75%) of patients, (6.25%) 
have moderate and mild grades of lymphocytes Fas 
expression. Hypersecretion of PGII determined in 
(76.25%) of patients, (25%) have moderate grade of 
lymphocytes Fas, (55%) was mild. Significant 
difference in grade of lymphocytes Fas (p value < 
0.001) with correlation between PGII levels and grade 
of gastric lymphocytes Fas (p value = 0.035). 
Significant difference in gastric lymphocytes Fas (p 
value < 0.001) with correlation between serum 
PGI/PGII and grade of gastric lymphocytes Fas 
expression (p value = 0.046). 
 
Table 4: Correlation of Gastric lamina propria, gastric glands Fas gene expression and gastric secretion 
Parameters Gastric Fas gene expressed in lamina propria 
2
 
 
P value r P value 
˂5% 5-25% 26-50% 50% ˃ Total 
Cag A 
genotype  
Positive  0 (0%) 32 (40%) 15 (18.75%) 0 (0%) 47 (58.75%) 
44.315 0.001 -0.215 0.056 
Negative  0 (0%) 13 (16.25%) 20 (25%) 0 (0%) 33 (41.25%) 
Pgi 
˂30  µg/l 0 (0%) 6 (7.5%) 0 (0%) 0 (0%) 6 (7.5%) 
782.410 0.000 -.212 0.05 30-160 µg/L 0 (0%) 19 (23.75%) 30 (37.5%) 0 (0%) 49 (61.25%) 
˃160 µg/L 0 (0%) 20 (25%) 5 (6.25%) 0 (0%) 25 (31.25%) 
Pgii 
˂3  µg/l 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 
746.31 0.000 -0.361 0.001 3-15 µg/L 0 (0%) 7 (8.75%) 12 (15%) 0 (0%) 19 (23.75%) 
˃15 µg/L 0 (0%) 38 (47.5%) 23 (28.75%) 0 (0%) 61 (76.25%) 
Pgi/pgii  
˂3  µg/l 0 (0%) 19 (23.75%) 14 (17.5%) 0 (0%) 33 (41.25%) 
1300.262 0.000 -0.073 0.519 3-20 µg/L 0 (0%) 26 (32.5%) 21 (26.25%) 0 (0%) 47 (58.75%) 
˃20 µg/L 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 
Gastrin17 ˂ 1 pmol/ml 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 
444.840 0.000 -0.064 0.575 1-7 pmol/ml 0 (0%) 40 (50%) 30 (37.5%) 0 (0%) 70 (87.5%) 
˃7 pmol/ml 0 (0%) 5 (6.25%) 5 (6.25%) 0 (0%) 10 (12.5%) 
Parameters Fas gene expressed in  Gastric glands X2 P value r P value 
Cag A 
genotype  
Positive  0 (0%) 2 (2.5%) 21 (26.25%) 24 (30%) 47 (58.75%) 
42.496 0.000 0.037 0.743 
Negative  0 (0%) 2 (2.5%) 12 (15%) 19 (23.75%) 33 (41.25%) 
Pgi 
˂30  µg/l 0 (0%) 0 (0%) 0 (0%) 6 (7.5%) 6(7.5%) 
723.02 0.000 -0.118 0.296 30-160 µg/L 0 (0%) 4 (5%) 22 (27.5%) 23 (28.75%) 49 (61.25%) 
˃160 µg/L 0 (0%) 0 (0%) 11 (13.75%) 14 (17.5%) 25 (31.25%) 
Pgii 
˂3  µg/l 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 
673.75 0.000 0.08 0.501 3-15 µg/L 0 (0%) 0 (0%) 7 (8.75%) 12 (15%) 19 (23.75%) 
˃15 µg/L 0 (0%) 4 (5%) 26 (32.5%) 31 (38.75%) 61 (76.25%) 
Pgi/pgii  
˂3  µg/l 0 (0%) 4 (5%) 5 (6.25%) 24 (30%) 33 (41.25%) 
1067.56 0.000 0.008 0.947 3-20 µg/L 0 (0%) 0 (0%) 28 (35%) 19 (23.75%) 47 (58.75%) 
˃20 µg/L 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 
Gastrin17 ˂ 1 pmol/ml 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 
363.42 0.000 0.121 0.286 1-7 pmol/ml 0 (0%) 4 (5%) 30 (37.5%) 36 (45%) 70 (87.5%) 
˃7 pmol/ml 0 (0%) 0 (0%) 3 (3.75%) 7 (8.75%) 10 (12.5%) 
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Table 5: Correlation of Lymphocytes Fas gene and gastric secretion 
Parameters 
Lymphocyte Fas gene 

2
 P value r P value 
˂5% 5-25% 26-50% 50% ˃ Total 
Cag A genotype 
Positive 0 (0%) 22 (27.5%) 25 (31.25%) 0 (0%) 47 (58.75%) 
51.219 0.000 0.179 0.112 
Negative 2 (2.5%) 27 (33.75%) 4 (5%) 0 (0%) 33 (41.25%) 
PGI 
˂30  µg/L 0 (0%) 5 (6.25%) 1 (1.25%) 0 (0%) 6 (7.5%) 
763.23 0.000 -0.291 0.009 30-160 µg/L 2 (2.5%) 28 (35%) 17 (21.25%) 0 (0%) 47 (58.75%) 
˃160 µg/L 4 (5%) 16 (20%) 7 (8.75%) 0 (0%) 27 (33.75%) 
PGII 
˂3  µg/L 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 
644.31 0.000 0.236 0.035 3-15 µg/L 0 (0%) 5 (6.25%) 5 (6.25%) 0 (0%) 10 (12.5%) 
˃15 µg/L 6 (7.5%) 44 (55%) 20 (25%) 0 (0%) 70 (87.5%) 
PGI/PGII ratio 
˂3  µg/L 2 (2.5%) 18 (22.5%) 13 (16.25%) 0 (0%) 33 (41.25%) 
1259.89 0.000 -0.224 0.046 3-20 µg/L 4 (5%) 31 (38.75%) 12 (15%) 0 (0%) 47 (58.75%) 
˃20 µg/L 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 
Gastrin17 
˂ 1 pmol/ml 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 
494.53 0.000 -0.050 0.663 1-7 pmol/ml 6 (7.5%) 39 (48.75%) 25 (31.25%) 0 (0%) 70 (87.5%) 
˃7 pmol/ml 0 (0%) 10 (12.5%) 0 (0%) 0 (0%) 10 (12.5%) 
Parameters PMNs Fas gene 
2
 P value r P value 
Cag A genotype 
Positive 20 (25%) 24 (30%) 3 (3.75%) 0 (0%) 47 (58.75%) 
29.177 0.015 0.262 0.019 
Negative 23 (28.75%) 10 (12.5%) 0 (0%) 0 (0%) 33 (41.25%) 
PGI 
˂30  µg/L 3 (3.75%) 3 (3.75%) 0 (0%) 0 (0%) 6 (7.5%) 
654.03 0.000 -0.296 0.008 30-160 µg/L 21 (26.25%) 25 (31.25%) 3 (3.75%) 0 (0%) 49 (61.25%) 
˃160 µg/L 16 (20%) 9 (11.25%) 0 (0%) 0 (0%) 25 (31.25%) 
PGII 
˂3  µg/L 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 
534.59 0.000 -.018 0.874 3-15 µg/L 9 (11.25%) 7 (8.75%) 3 (3.75%) 0 (0%) 19 (23.75%) 
˃15 µg/L 31 (38.75%) 30 (37.5%) 0 (0%) 0 (0%) 61 (76.25%) 
PGI/PGII 
˂3  µg/L 16 (20%) 17 (21.25%) 0 (0%) 0 (0%) 33 (41.25%) 
1033.23 0.000 -0.014 0.905 3-20 µg/L 24 (30%) 20 (25%) 3 (3.75%) 0 (0%) 47 (58.75%) 
˃20 µg/L 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 
Gastrin17 
˂ 1 pmol/ml 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 
324.95 0.000 -0.007 0.952 1-7 pmol/ml 34 (42.5%) 33 (41.25 %) 3 (3.75%) 0 (0%) 70 (87.5 %) 
˃7 pmol/ml 6 (7.5 %) 4 (5%) 0 (0%) 0 (0%) 10 (12.5 %) 
 
 
Significant difference in grade of Fas 
expression (p value < 0.001) without correlation 
between level of gastrin17 and grade of gastric 
lymphocyte Fas expression (p value = 0.663). 
Significant difference with correlation between CagA 
expression and grade of PMNs Fas (p value = 0.015, 
p value = 0.019), (Table 5). Significant difference in 
grade of PMNs Fas (p value < 0.001) with significant 
correlation between level of PGI and PMNs Fas grade 
(p value = 0.008). Significant difference in grade of 
PMNs Fas (p value < 0.001) without correlation with 
PGII level (p value = 0.874). Significant difference in 
grade of PMNs Fas expression (p value < 0.001) 
without correlation between level of PGI/PGII and 
grade of PMNs Fas (p value = 0.905). Normal 
gastrin17 detected in (87.5%), (3.75%) have moderate 
PMNs Fas grade, (41.25 %) have mild PMNs Fas.  
Table 6:  Correlation of cellular Fas gene and gastric secretion 
  Parameters 
Cellular Fas gene expressed in epithelia 

2
 P value r P value 
˂5% 5-25% 26-50% 50% ˃ Total 
Cag A genotype 
Positive 0 (0%) 25 (31.25%) 22 (27.5%) 0 (0%) 47 (58.75%) 
43.225 0.000 -0.104 0.358 
Negative 0 (0%) 19 (23.75%) 14 (17.5%) 0 (0%) 33 (41.25%) 
PGI 
˂30  µg/L 0 (0%) 4 (5%) 2 (2.5%) 0 (0%) 6 (7.5%) 
762.552 0.000 0.038 0.737 30-160 µg/L 0 (0%) 27 (33.75%) 22 (27.5%) 0 (0%) 49 (61.25%) 
˃160 µg/L 0 (0%) 13 (16.25%) 12 (15%) 0 (0%) 25 (31.25%) 
PGII 
˂3  µg/L 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 
689.201 0.000 0.148 0.191 3-15 µg/L 0 (0%) 15 (18.75%) 4 (5%) 0 (0%) 19 (23.75%) 
˃15 µg/L 0 (0%) 29 (36.25%) 32 (40%) 0 (0%) 61 (76.25%) 
PGI/PGII  
˂3  µg/L 16 (20%) 17 (21.25%) 0 (0%) 0 (0%) 33 (41.25%) 
1120.384 0.000 -0.068 0.547 3-20 µg/L 24 (30%) 20 (25%) 3 (3.75%) 0 (0%) 47 (58.75%) 
˃20 µg/L 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 
Gastrin17 
˂ 1 pmol/ml 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 
341.613 0.000 -0.098 0.388 1-7 pmol/ml 34 (42.5%) 33 (41.25%) 3 (3.75%) 0 (0%) 70 (87.5%) 
˃7 pmol/ml 6 (7.5%) 4 (5%) 0 (0%) 0 (0%) 10 (12.5%) 
Parameters 
Cellular Fas gene expressed in lamina propria 
˂5% 5-25% 26-50% 50% ˃ Total 
2
 P value r P value 
Cag A genotype 
Positive 0 (0%) 32 (40%) 15 (20%) 0 (0%) 47 (58.75%) 
44.395 0.001 -.215 0.056 
Negative 0 (0%) 13 (16.25%) 20 (25%) 0 (0%) 33 (41.25%) 
PGI 
˂30  µg/L 0 (0%) 3 (3.75%) 3 (3.75%) 0 (0%) 6 (7.5%) 
762.552 0.000 -0.038 0.737 30-160 µg/L 0 (0%) 22 (27.5%) 27 (33.75%) 0 (0%) 49 (61.25%) 
˃160 µg/L 0 (0%) 20 (25%) 5 (6.25%) 0 (0%) 25 (31.25%) 
PGII 
˂3  µg/L 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 
689.201 0.000 0.148 0.191 3-15 µg/L 0 (0%) 0 (0%) 0 (0%) 19 (23.75%) 19 (23.75%) 
˃15 µg/L 0 (0%) 0 (0%) 0 (0%) 61 (76.25%) 61 (76.25%) 
PGI/PGII  
˂3  µg/L 0 (0%) 19 (23.75%) 14 (17.5%) 0 (0%) 33 (41.25%) 
1120.384 0.000 0.068 0.547 3-20 µg/L 0 (0%) 26 (32.5%) 21 (26.25%) 0 (0%) 47 (58.75%) 
˃20 µg/L 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 
Gastrin17 
˂ 1 pmol/ml 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 
586.079 0.000 0.020 0.858 1-7 pmol/ml 0 (0%) 40 (50%) 30 (37.5%) 0 (0%) 70 (87.5%) 
˃7 pmol/ml 0 (0%) 5 (6.25%) 5 (6.25%) 0 (0%) 10 (12.5%) 
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Hypergastrinemia detected in (12.5%), (5%) 
have mild grade of PMNs Fas. Significant difference in 
grade of PMNs Fas (p value < 0.001) without 
correlation between serum gastrin17 and grade of 
gastric glands Fas (p value = 0.952). 
As shown in Table 6, moderate grade of 
PMNs & lymphocytes Fas in gastric epithelia reported 
in (27.5%) of cases, (31.25%) have mild expression. 
Significant difference without correlation between 
CagA and grade of PMNs & lymphocytes Fas 
expression (p value = 0.015, p value = 0.358). 
Significant difference among disorders in grade of 
PMNs &lymphocytes Fas expression (p value < 
0.001) without significant correlation between PGI 
levels and grade of PMNs & lymphocytes Fas 
expression (p value = 0.737). Significant difference 
among disorders in grade of PMNs & lymphocytes 
Fas (p value < 0.001) without correlation with PGII 
levels (p value = 0.191). Hyposecretion of PGI/PGII 
detected in (41.25%), (21.25%) have mild grade of 
PMNs & lymphocytes Fas expression. Significant 
difference in grade of PMNs & lymphocytes Fas (p 
value < 0.001) without correlation (p value = 0.547). 
Significant difference among disorders in grade of 
PMNs Fas expression (p value < 0.001) without 
correlation between serum level of gastrin-17 and 
grade of PMNs & lymphocytes Fas expression (p 
value = 0.388).  
As shown in Table 6, significant difference 
with marginal correlation between CagA gene 
expression and grade of PMNs & lymphocytes Fas (p 
value = 0.001, p value = 0.056). Significant difference 
in grade of PMNs & lymphocytes Fas (p value < 
0.001) without significant correlation between serum 
level of PGI and grade of PMNs &lymphocytes Fas (p 
value = 0.737). Significant difference among disorders 
in grade of PMNs & lymphocytes Fas (p value < 
0.001) without correlation with PGII levels (p value = 
0.191).  
 As shown in Table 6, significant difference 
among disorders in grade of PMNs & lymphocytes 
Fas expression in lamina propria (p value < 0.001) 
without correlation (p value = 0.547). Significant 
difference among disorders in grade of PMNs Fas 
gene (p value < 0.001) without correlation between 
level of gastrin-17 and grade of PMNs & lymphocytes 
Fas expression (p value = 0.858). 
 
 
Discussion 
 
In this cross sectional study, (80) of H. pylori 
infected patients, age range 16-80 years, mean (47.24 
± 18.82) years were studied. The frequency of H. 
pylori associated disorders in current study starting 
from gastritis (37.5%), gastropathy & gastric ulcer 
(18.75%), DU(15%), duodenitis (7.5%), prepyloric 
ulcer (2.5%) which come in line with others[4] . 
In current study high grade of Fas gene 
expression was not detected at all. Mild lymphocytes 
expression (5-25%) reported in (61.25%), followed by 
moderate grade (26-50%) of expression (31.25%) 
among different disorders. In PMNs, mild Fas 
expression was reported in (46.25%) versus (3.75%) 
moderate the frequency of Fas gene expression more 
frequently reported in gastritis and gastropathy. Even 
there was significant difference in lymphocytes Fas 
expression among disorders, there was no correlation 
between this expression and type of gastric disorder. 
This is a logical finding because the induction of Fas 
expression via infiltrating lymphocytes and PMNs is 
associated and attributed to the induction via H. pylori 
infection [10]. Low Fas expression in infiltrating PMNs 
compared with infiltrating lymphocytes may attributed 
to the chronic active inflammatory reaction among 
different disorders [11]. 
One of interesting points that the lymphocytes 
and PMNs Fas expression in epithelial lining range 
from mild (gastric ulcer; gastritis; gastropathy) to 
moderate ( gastritis ; DU; gastropathy) with significant 
difference. While in lamina propria, infiltrating 
lymphocytes and PMNs among all disorders have 
high grade of Fas gene expression. This may 
attributed to the ability of H. pylori to invade deeply in 
gastric tissue gastric beyond mucosal epithelia, which 
indicates initiation of interaction between H. pylori and 
inflammatory cells in lamina propria leading to 
activation of NFkB gene in gastric as well as 
Lymphocytes and PMNs, finally IL8 production and 
increase oxidative stress in gastric tissue leading final 
to increase Fas gene production which is more 
obvious in lamina propria than in gastric epithelia, 
reflecting the underling pathology in near future [1, 10, 
11].  
In current study CagA genotype have a 
positive effect and correlation on the gastric cells Fas 
over expression in (43.75%). Mild expression detected 
in (10%). This results come in line with [1, 10]. This 
result come in concordance with opinion of [10, 18] 
stated that whenever H. pylori have potent Cag PAI, 
bacterial adhesion, good signals will be received by 
the gastric epithelial cells which reflect its response by 
increasing of expression of MHCII to play as antigen 
presenting cell (APC) and strong Th1 response will be 
occur with obvious IFNγ secretion which acts as good 
stimulator for up-regulation of FAS and even FASL in 
gastroduodenal tissue and tissue infiltrating 
lymphocytes (TILs).  
One of exciting things in this study, the 
fluctuation of gastric Fas expression independently 
from a status of gastric hormones. All cases with 
hyposecretion of PGI; PGI/PGII characterized by 
gastric Fas overexpression, (7.5%) vs. (27.5%). On 
the other hand all cases with normal gastric hormone 
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level also associated with gastric Fas overexpress, 
PGI (31.25%), PGII (15%), PGI/PGII (33.75%), G17 
(56.25%) without any significant correlation between a 
status of PGI, PGI/PGII, Gastrin 17 and gastric Fas 
overexpression. PGII have positive correlation with 
gastric Fas overexpression among different disorders.  
These results indicating a H. pylori induced 
pangastric type of mucosal inflammation even to 
duodenal region that reflects the disruption in gastric 
hormones secretion mainly over production of PGI 
(31.25%), PGII (76.25%), G17 (5%) [19]. Gastric Fas 
expression and gastric hormones have indirect 
correlation. Mucosal colonization by the H. pylori 
ignites a cascade of events that result in large 
increases in inflammatory cytokines in the infected 
tissue which were originated from the gastric mucosa 
as well as from infiltrating inflammatory cells. Among 
these inflammatory cytokines, IL-1, IL-2, TNF-α, and 
IFNγ that have been shown to up-regulate the 
expression of Fas antigen in gastric as well as 
inflammatory cells. T-helper type 1 (Th1) cells are 
selectively increased during H. pylori infection [20]. 
Th1 cytokines, such as IFNγ and TNF-α, can increase 
the release of proinflammatory cytokines, such as IL-8 
from the epithelium as well as Fas and Fas ligand 
(FasL) 34. Furthermore, these cytokines can also 
increase the expression of MHC class II molecules by 
gastric epithelial cells, thereby increasing the binding 
of H. pylori to the gastric epithelium [21].  
One of frustrating things that there was no 
clinical study to evaluates the correlation between 
gastric Fas expression and the level of gastric 
hormones. One of remarkable finding in current study 
when making topographical analysis for the 
correlation between gastric hormones and gastric Fas 
expression in gastric epithelia, lamina propria and 
gastric glands. This study reported a positive 
correlation between gastric Fas expression and 
PGI;PGII in gastric epithelia, lamina propria but not in 
gastric gland even with presence of significant 
difference in gastric hormones according to Fas gene 
expression.  
Attachment of H. pylori on specific molecules 
expressed and acts as a receptor in the gastric 
epithelia, MHCII and CD74 using multiple adhesins 
that have been identified on the outer membrane of H. 
pylori such as BabA, SabA. BabA and SabA bind to 
fucosylated and sialylated blood group antigens, 
respectively. While the attachment of H. pylori using 
BabA as an adhesin does not appear to induce 
signaling or immune responses from host cells, SabA 
appears to be required for activation of neutrophils 
and the resulting oxidative burst by binding to 
sialylated neutrophil receptors [22]. This inflammatory 
signal extended throughout gastric epithelia to lamina 
propria also via the effect of neutrophil activating 
protein and urease as well as CagA production by H. 
pylori which in turn leads to activation of lymphocytes 
and gastric NFkB causing production of 
proinflammatory cytokines, mainly IL8 and hence the 
gastric epithelia and lamina propria sinking with 
inflammatory reaction and cells leading to increase of 
Fas expression on gastric epithelia and lamina propria 
as well as inflammatory cells [1, 11, 23]. Because 
CagA interacts with important signaling mediators in 
the gastric cells, it is considered responsible for 
changes in cell morphology, adhesion and turnover 
[23]. CagA cause increase in Fas expression 
independently or in conjunction with other virulence 
factors such as urease [10, 11]. At the same time as a 
results of pan gastric inflammatory reaction this leads 
to direct effects on PGII producing cells causing 
increase in PGII production and as a results of 
neuroendocrine activity through vagus nerve and 
gastrin, PGI also affected. Fas expression on gastric 
glands has no correlation with gastric hormones even 
in the presence of significant differences in hormones 
according to grade of Fas expression may be 
associated with fact that gastric glands appear to be 
Immunological privileged site.  
In current study, H. pylori influence on 
apoptosis of lymphocytes in gastric mucosa 
.lymphocytes Fas expression has positive correlation 
with PGI; PGII, PGI/PGII. Obvious fluctuation of 
lymphocytes Fas according to gastric hormones from 
mild to moderate expression as in Table 5. One of 
remarkable finding was the mild to moderate 
expression of Fas on PMNS which has positive 
correlation with PGI serum level only. This may 
attributed to chronic active pangastric inflammation 
affecting the PGI, PGII producing chief cells within 
gastric mucosa, reflecting by (3.75%) mild expression 
of PMNs, (6.25%) in lymphocytes and clinically 
patients suffered from atrophic corpus gastritis. The 
mild to moderate expression of Fas on gastric tissue 
infiltrating lymphocytes give an indication about the 
immunopathological role of these cells in underling 
clinical diseases .by relatively low expression of 
apoptotic marker (Fas) in lymphocytes as well as 
PMNs this will leads to delay spontaneous apoptosis 
and prolong their survival. It results in the prolonged 
activity of cytokines secreted by these cells and 
therefore augments their damaging action upon 
gastric mucosa [24, 25]. On the other hand the mild to 
moderate expression of Fas receptors on lymphocytes 
and PMNs act in delay of their proliferation and affects 
its ability to get rid of H. pylori from gastric tissue, and 
at sum this will cause persistence infection and a 
protective strategy for H. pylori [24, 26].  
When making topographical analysis for the 
correlation between gastric hormones and 
inflammatory cells (lymphocytes & PMNs) Fas 
expression in gastric epithelia, lamina propria; No 
correlation was reported between inflammatory cells 
(lymphocytes & PMNs) Fas expression and gastric 
hormones secretion in gastric epithelia, lamina propria 
even with presence of significant difference in gastric 
hormones according to Fas gene expression as in 
Table 6. This finding reflect the role of; and give an 
 AL-Ezzy. Immunomodulatory Effect of H. Pylori Cag A Genotype and Gastric Hormones 
_______________________________________________________________________________________________________________________________ 
_______________________________________________________________________________________________________________________________ 
Open Access Maced J Med Sci. 2016 Sep 15; 4(3):364-373.                                                                                                                                                         373 
 
indication that H. pylori acts as inducer for Fas gene 
expression on gastric cells as well as lymphocytes & 
PMNs, directly through its virulence factors, mainly 
products of Cag pathogenicity island, CagA and 
others, and indirectly through cytokines produce by 
TH1 cells such as IFNγ as well as the oxidative stress 
produced by reactive oxygen species from 
inflammatory cells infiltrated into gastric tissue due to 
H. pylori infection [10, 11, 24].  
In conclusion, Fas gene expression and 
localization on gastric and inflammatory cells affected 
directly by H. pylori CagA and indirectly by gastric 
hormones. This contributes to progression of various 
gastric disorders according to severity of CagA 
induced gastric pathology and gastric hormones 
disturbance throughout the course of infection and 
disease.  
 
References 
1. Al-Ezzy AIA. Molecular and Immunopathological role of Gastric 
versus lymphocytes Interleukin 8 Gene Expression in H. pylori 
induced Fas-Fasl apoptotic pathway in Gastroduodenal Ulcer in 
Iraqi patients. Journal of Biology, Agriculture and Healthcare. 
2015;5:141-53. 
2. AL-Ezzy AIA. Evaluation of Clinicopathological and Risk Factors 
for Nonmalignant H. Pylori Associated Gastroduodenal Disorders 
in Iraqi Patients. OA Maced J Med Sci. 2015;3:655-60.  
http://dx.doi.org/10.3889/oamjms.2015.113 
 
3. Shafii M, Nikzad SE, Kasiri H, Naghipour M. Histopathological 
evaluation of chronic gastritis with and without Helicobacter pylori 
colonization: a study from Iran. Malays J Pathol. 2008;30:27-30. 
PMid:19108408 
 
4. Xu X-Q, Wang Z-H, Liao J-X, Chen X-Y, Liu W-Z, Xiao S-D, et 
al. Predictive value of neutrophil infiltration as a marker of 
Helicobacter pylori infection. World journal of gastroenterology: 
WJG. 2012;18:5101. 
http://dx.doi.org/10.3748/wjg.v18.i36.5101 
PMid:23049221 PMCid:PMC3460339 
 
5. Chowers MY, Keller N, Tal R, Barshack I, Lang R, Bar-Meir S, et 
al. Human gastrin: a Helicobacter pylori specific growth factor. 
Gastroenterology. 1999;117:1113-8. 
http://dx.doi.org/10.1016/S0016-5085(99)70396-3 
 
6. Rau T, Sonst A, Rogler A, Burnat G, Neumann H, Oeckl K, et al. 
Gastrin mediated down regulation of ghrelin and its 
pathophysiological role in atrophic gastritis. J Physiol Pharmacol. 
2013;64:719-25. PMid:24388886 
 
7. Sarker SA, Sultana S, Sattar S, Ahmed T, Beglinger C, Gyr N, et 
al. Influence of Helicobacter pylori Infection on Gastric Acid 
Secretion in PreSchool Bangladeshi Children. Helicobacter. 
2012;17:333-9. 
http://dx.doi.org/10.1111/j.1523-5378.2012.00965.x 
PMid:22967116 
 
8. Galmiche A, Rassow J, Doye A, Cagnol S, Chambard JC, 
Contamin S, de Thillot V, Just I, Ricci V, Solcia E, Van Obberghen 
E, Boquet P. The N-terminal 34 kDa fragment of Helicobacter pylori 
vacuolating cytotoxin targets mitochondria and induces cytochrome 
c release. EMBO J. 2000;19(23):6361-70. 
http://dx.doi.org/10.1093/emboj/19.23.6361 
PMid:11101509 PMCid:PMC305856 
 
9. Fan X, Gunasena H, Cheng Z, Espejo R, Crowe SE, Ernst PB, 
Reyes VE. Helicobacter pylori urease binds to class II MHC on 
gastric epithelial cells and induces their apoptosis. J Immunol. 
2000;165(4):1918-24. 
http://dx.doi.org/10.4049/jimmunol.165.4.1918 
PMid:10925273 
 
10. AL-Ezzy AIA. Immunopathological Role of FAS-FASL Apoptotic 
Pathway in H. pylori CagA Positive Associated Chronic Atrophic 
Gastritis in Iraqi Patients. Journal of Biology, Agriculture and 
Healthcare. 2014;4:67-74. 
 
11. Al-Ezzy AIA. Molecular and Immunopathological role of nuclear 
factor k b detected by insitu hybridization in pathogenesis of 
chronic atrophic gastritis in Iraqi patients. International Journal of 
Advanced Research. 2014;2:67-78. 
 
12. Serim RC. PyloriTek® For H. pylori http://www.serim.com. 
 
13. Subbukesavaraja V, Balan K. Comparative study of invasive 
methods for diagnosis of Helicobacter pylori in humans. Int J Curr 
Microbiol App Sci. 2013;2:63-8. 
 
14. Tzeng J-E, Lin Y-L, Chung S-M, Chu Y-T. Comparison of four 
diagnostic methods for Helicobacter pylori. Tzu Chi Med J. 
2005;17:339-43. 
 
15. Maxim biotech. Insitu hybridization detection system. 
 
16. Pity IS, Baizeed AM. Identification of helicobacter pylori in 
gastric biopsies of Patients with chronic gastritis: histopathological 
and Immunohistochemical study. Duhok Medical Journal. 2011;5. 
 
17. Biohit H. Biohit gastro panel http://www.biohithealthcare.co.uk/. 
 
18. Zhang Z-W, Dorrell N, Wren BW, Farthing MJ. Helicobacter 
pylori adherence to gastric epithelial cells: a role for non-adhesin 
virulence genes. Journal of medical microbiology. 2002;51:495-
502. 
http://dx.doi.org/10.1099/0022-1317-51-6-495 
PMid:12018657 
 
19. Marcis L, Sanita L, Inese P, Dace R, Ilona V, Ilva D, et al. 
Pepsinogen testing for evaluation of the success of 
Helicobacterpylori eradication at 4 weeks after completion of 
therapy. Medicina. 2015;50:8-13. 
 
20. Bamford KB, Fan X, Crowe SE, Leary JF, Gourley WK, Luthra 
GK, et al. Lymphocytes in the human gastric mucosa during 
Helicobacter pylori have a T helper cell 1 phenotype. 
Gastroenterology. 1998;114:482-92. 
http://dx.doi.org/10.1016/S0016-5085(98)70531-1 
 
21. Fan X, Crowe SE, Behar S, Gunasena H, Ye G, Haeberle H, et 
al. The effect of class II major histocompatibility complex 
expression on adherence of Helicobacter pylori and induction of 
apoptosis in gastric epithelial cells: a mechanism for T helper cell 
type 1mediated damage. The Journal of experimental medicine. 
1998;187:1659-69. 
http://dx.doi.org/10.1084/jem.187.10.1659 
PMid:9584144 PMCid:PMC2212295 
 
22. Unemo M, Aspholm-Hurtig M, Ilver D, Bergström J, Borén T, 
Danielsson D, et al. The sialic acid binding SabA adhesin of 
Helicobacter pylori is essential for nonopsonic activation of human 
neutrophils. J Biol Chem. 2005;280:15390-7. 
http://dx.doi.org/10.1074/jbc.M412725200 
PMid:15689619 
 
23. Beswick EJ, Suarez G, Reyes VE. H. pylori and host 
interactions that influence pathogenesis. World J Gastroenterol. 
2006;12:5599-605. PMid:17007010 PMCid:PMC4088158 
 
24. Kotłowska-Kmieć A, Bąkowska A, Szarszewski A, Kamińska B, 
Łuczak G, Radys W, et al. Helicobacter pylori increases expression 
of proapoptotic markers Fas and FasL on CD4 lymphocytes in 
children. Acta Biochemica Polonica. 2009;56:433-8. 
PMid:19572057 
 
25. Bussiere F, Chaturvedi R, Asim M. Low multiplicity of infection 
of Helicobacter pylori suppresses apoptosis of B lymphocytes. 
Cancer Res. 2006;66:6834-42. 
http://dx.doi.org/10.1158/0008-5472.CAN-05-4197 
PMid:16818661 
 
26. Schmees C, Prinz C, Treptau T, Rad R, Hengst L, Voland P, et 
al. Inhibition of T-cell proliferation by Helicobacter pylori -glutamyl 
transpeptidase. Gastroenterology. 2007;132:1820-33. 
http://dx.doi.org/10.1053/j.gastro.2007.02.031 
PMid:17484877 
 
 
